share_log

A股午间公告:格林美签署共同推动大规模设备更新和消费品以旧换新战略合作协议

A-share midday announcement: Grimmie signs strategic cooperation agreement to jointly promote large-scale equipment upgrades and consumer goods trade-in

Gelonghui Finance ·  Apr 30 00:40

① Grimmie: The company and 21 partners including Shenzhen SF Integrated Logistics Service Co., Ltd., Guangzhou Shiyuan Electronic Technology Co., Ltd., Jingjin Equipment Co., Ltd., Suzhou Huichuan Technology Co., Ltd., Fangzheng Valve Group Co., Ltd., Shandong Tianli Energy Co., Ltd., Weiming Environmental Protection Equipment Group Co., Ltd., Emerson Process Control Co., Ltd. signed a strategic cooperation agreement on April 30 to jointly build a digital recycling platform, establish a reverse recycling logistics supply chain service system, and carry out equipment upgrade and remanufacturing, and online construction of remanufacturing equipment and used equipment The following shows the big market system for supply chain sales.

② Linuo Tebo: The company's borosilicate glass molded injection bottle recently passed the technical review by the National Drug Administration Drug Evaluation Center (“CDE”), and the registration number has changed to an “A” status on the CDE API, pharmaceutical excipients and pharmaceutical packaging materials registration information disclosure platform, indicating that the borosilicate glass molded injection bottles produced by the company can be officially sold in batches.

③ HiCisco: Due to changes in the market and competitive environment in recent years, there is great uncertainty about market entry and commercialization prospects in China. The company carefully considered the investment risk and future market and competition risks in the continued development of riluzole oral solution films, plans to terminate the licensing and introduction agreement with Aquestive for riluzole oral solution, and will stop related development and import registration work. At the same time, based on the principle of accounting prudence, the full amount of asset impairment preparations for other non-current assets formed by the introduction project. In addition, the company plans to establish a subsidiary, Tibet Haikang Innovative Pharmaceutical Research Co., Ltd., no more than 5 million yuan.

④ Haowu Co., Ltd.: On April 29, for the first time, the company repurchased 90,000 shares of the company's shares through a special securities account for share repurchases. The highest transaction price was 3.25 yuan/share, the lowest transaction price was 3.25 yuan/share, and the total transaction price was 292,500 yuan (excluding transaction fees).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment